Clinical Research Directory

Resting Metabolic Rate in Bodybuilders Using Performance-Enhancing Drugs

Sponsor: Atlantica - Instituto Universitario

Summary

Bodybuilders present unique body composition profiles, characterized by high fat-free mass and very low levels of body fat. In addition, many competitive and non-competitive athletes use anabolic-androgenic steroids (AAS) and fat-burning pharmacological agents to enhance muscle mass and accelerate fat loss. Accurate determination of energy requirements is critical for performance and nutritional planning in this population. Resting metabolic rate (RMR) represents the largest component of daily energy expenditure. While indirect calorimetry is considered the reference method to assess RMR, it is expensive and not widely accessible, making predictive mathematical equations the primary tool used in sports and clinical settings. However, widely used equations (such as Harris-Benedict, Mifflin-St Jeor, and Cunningham) were developed in general or non-athletic populations and may systematically underestimate energy requirements in bodybuilders using performance-enhancing substances. The primary aim of this cross-sectional study is to measure resting metabolic rate via indirect calorimetry and body composition via dual-energy X-ray absorptiometry (DXA) in adult bodybuilders using anabolic and fat-burning agents. The ultimate goal is to develop and validate a population-specific predictive equation for RMR and compare its accuracy against established predictive formulas.

Official title: Development of a Predictive Equation for Resting Metabolic Rate in Bodybuilders Using Anabolic and Fat Burning Pharmacological Agents

Key Details

Conditions

Interventions

Locations (1)